Open access · CC-BY
via OpenAlex
Therapeutic Potential of Micheliolide and ACT001 in Age-Related Diseases: Molecular Mechanisms and Clinical Prospects
Aging and Disease · 2026
Deregulated nutrient-sensing
Mitochondrial dysfunction
Altered intercellular communication
Chronic inflammation
Disabled macroautophagy
Human
Abstract
Aging is the predominant risk factor for several chronic disorders; therefore, elucidating the molecular and cellular mechanisms underlying age-related pathologies is essential for therapeutic advancement. Micheliolide (MCL), a naturally occurring guaianolide sesquiterpene lactone derived from Michelia champaca and Michelia compressa, has attracted increasing attention for its pharmacological potential. Its derivative, ACT001, enables the sustained release of MCL into the plasma in vivo, thereby enhancing oral bioavailability and improving therapeutic efficacy. ACT001 has recently received orphan drug designation for glioblastoma treatment, highlighting its clinical feasibility and safety profile. Increasing evidence indicates that MCL regulates age-related diseases by modulating inflammation, cell cycle, mitochondrial dysfunction(definition), oxidative stress, and autophagy(definition). By targeting key signaling pathways, including NF-κB, STAT3, NRF2, AMPK, and NLRP3, MCL/ACT001 demonstrated its protective effect against age-related diseases. This paper summarizes the current mechanistic insight and disease-specific evidence regarding MCL/ACT001 and further evaluates their therapeutic repositioning potential for age-related diseases, including cardiovascular and cerebrovascular diseases, fibrotic conditions, immune disorders, metabolic diseases, and tumors. Additionally, we discussed key translational challenges.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.14336/ad.2025.1556
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Xu, H., Cong, X., & Lin, L. (2026). Therapeutic Potential of Micheliolide and ACT001 in Age-Related Diseases: Molecular Mechanisms and Clinical Prospects. <em>Aging and Disease</em>. https://doi.org/10.14336/ad.2025.1556
Vancouver
Xu H, Cong X, Lin L. Therapeutic Potential of Micheliolide and ACT001 in Age-Related Diseases: Molecular Mechanisms and Clinical Prospects. Aging and Disease. 2026. doi:10.14336/ad.2025.1556.
BibTeX
@article{h2026Therap,
title = {Therapeutic Potential of Micheliolide and ACT001 in Age-Related Diseases: Molecular Mechanisms and Clinical Prospects},
author = {H Xu and Xin Cong and Lian-Jun Lin},
journal = {Aging and Disease},
year = {2026},
doi = {10.14336/ad.2025.1556},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stresses 2026
Open access · CC-BY
Hormetic Stress Responses in Aging: From Molecular Mechanisms to Clinical Translation
Die Pharmazie 2025
Open access · CC-BY
Metformin and the molecular pathways of aging: Searching for the modern elixir of life
Reproductive sciences (Thousand Oaks, Calif.) 2026
Citation only
Dual Roles of Autophagy in Endometrial Fibrosis and Its Implications in Age-Related Reproductive Dysfunction.
Oxidative Medicine and Cellular Longevity 2015
Open access · CC-BY
Polyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related Diseases
Biomedicine & Pharmacotherapy 2026
Open access · CC-BY
Telomerase and chronic inflammation as central molecular links in aging
BioMed Research International 2014
Open access · CC-BY